Læknablaðið - 15.04.2007, Page 18
Cipralex® escitalopram
Meðhöndlun á miðlungs til alvarlegu þunglyndi
Nýtt1, óháð, bein samanburðar-
rannsókn staðfestir fyrri niðurstöður.2
Cipralex® hefur marktækt betri verkun en
Cipramil® citalopram við meðhöndlun á
alvarlegu þunglyndi*
Hlutfall svörunar-*og sjúkdómshlés’”eftir 8 vikna meðhöndlun
Alvarlegt þunglyndi
* MADRS > 30
** Reduktion i MADRS score > 50%
*** MADRS score <12
Myndin er unnin af Lundbeck Pharma A/S eftir
mynd 3 frá Lancon, C. et al. 2006'
Heimildin
1) Lancon, C. et. al. Comparison of escitalopram and citalopram in outpatients with severe major depressive disorder: a prospective,
naturalistic, 8-week study International Journal of Psychiatry in Clinical Practice, 2006,10(2): 131-137.
2) Moore, N. et. al. Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram in outpatient treatment
of major depressive disordehitemational Clinical Psychopharmacology 2005,20:131-137.
Sérlyfjatexti á bls. 376
Ljuk Cipralex
---- I Jy * escitalopram